Ah Reum Khang1, Eu Jeong Ku2, Ye An Kim3, Eun Roh4, Jae Hyun Bae3, Tae Jung Oh5, Sang Wan Kim3,6, Chan Soo Shin3, Seong Yeon Kim3, Jung Hee Kim7. 1. Diabetes Center and Endocrine Clinic, Pusan National University Yangsan Hospital, Pusan, Republic of Korea. 2. Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea. 3. Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. 4. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. 5. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. 6. Department of Internal Medicine, Seoul Metropolitan Government Borame Medical Center, Seoul, Republic of Korea. 7. Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. jhkxingfu@gmail.com.
Abstract
PURPOSE: Hypopituitary patients have a reduced life expectancy owing to cardiovascular events. We investigated the prevalence of metabolic syndrome in hypopituitary patients for a follow-up period of at least 1 year in comparison with an age- and sex-matched nationwide control group. METHODS: A total of 515 patients with hypopituitarism who visited Seoul National University Hospital between January 2000 and December 2010 were included. Data for an age- and sex-matched control group were obtained from the Korean National Health and Nutrition Examination Surveys (KNHANES) (n = 1545). Metabolic syndrome was defined according to the modified National Cholesterol Education Program (NCEP-ATPIII). RESULTS: The prevalence of metabolic syndrome did not differ significantly between the hypopituitary and control groups for men (34.9 versus 30.3 %), but the risk of metabolic syndrome was higher in hypopituitary women than in controls (39.8 versus 28.5 %). In both sexes, the risks of central obesity and dyslipidemia were higher in the hypopituitary group than in the control group. Men had lower risks of hypertension and hyperglycemia in the hypopituitary group, which attenuated the risk of metabolic syndrome. Age greater than 40 years and obesity (BMI ≥25 kg/m2) contributed to a higher risk of metabolic syndrome. CONCLUSIONS: The metabolic syndrome prevalence was higher in the hypopituitry group than in the control group in Korean women, and this was attributed to an increased risk of central obesity and dyslipidemia. Accordingly, early intervention to reduce metabolic syndrome needed in hypopituitary patients, i.e. women.
PURPOSE: Hypopituitary patients have a reduced life expectancy owing to cardiovascular events. We investigated the prevalence of metabolic syndrome in hypopituitary patients for a follow-up period of at least 1 year in comparison with an age- and sex-matched nationwide control group. METHODS: A total of 515 patients with hypopituitarism who visited Seoul National University Hospital between January 2000 and December 2010 were included. Data for an age- and sex-matched control group were obtained from the Korean National Health and Nutrition Examination Surveys (KNHANES) (n = 1545). Metabolic syndrome was defined according to the modified National Cholesterol Education Program (NCEP-ATPIII). RESULTS: The prevalence of metabolic syndrome did not differ significantly between the hypopituitary and control groups for men (34.9 versus 30.3 %), but the risk of metabolic syndrome was higher in hypopituitary women than in controls (39.8 versus 28.5 %). In both sexes, the risks of central obesity and dyslipidemia were higher in the hypopituitary group than in the control group. Men had lower risks of hypertension and hyperglycemia in the hypopituitary group, which attenuated the risk of metabolic syndrome. Age greater than 40 years and obesity (BMI ≥25 kg/m2) contributed to a higher risk of metabolic syndrome. CONCLUSIONS: The metabolic syndrome prevalence was higher in the hypopituitry group than in the control group in Korean women, and this was attributed to an increased risk of central obesity and dyslipidemia. Accordingly, early intervention to reduce metabolic syndrome needed in hypopituitary patients, i.e. women.
Authors: Agatha A van der Klaauw; Nienke R Biermasz; Edith J M Feskens; Marieke B Bos; Johannes W A Smit; Ferdinand Roelfsema; Eleonora P M Corssmit; Hanno Pijl; Johannes A Romijn; Alberto M Pereira Journal: Eur J Endocrinol Date: 2007-04 Impact factor: 6.664
Authors: Roger Abs; Anders F Mattsson; Maria Thunander; Johan Verhelst; Miklós I Góth; Patrick Wilton; Maria Kołtowska-Häggström; Anton Luger Journal: Eur J Endocrinol Date: 2013-02-15 Impact factor: 6.664
Authors: Javier Martínez-Torres; Jorge Enrique Correa-Bautista; Katherine González-Ruíz; Andrés Vivas; Héctor Reynaldo Triana-Reina; Daniel Humberto Prieto-Benavidez; Hugo Alejandro Carrillo; Jeison Alexander Ramos-Sepúlveda; Emilio Villa-González; Antonio García-Hermoso; Robinson Ramírez-Vélez Journal: Int J Environ Res Public Health Date: 2017-02-27 Impact factor: 3.390
Authors: Hyung-Sub Jin; Eun-Bee Choi; Minseo Kim; Sarah Soyeon Oh; Sung-In Jang Journal: Int J Environ Res Public Health Date: 2019-11-14 Impact factor: 3.390
Authors: Elena Gangitano; Giuseppe Barbaro; Martina Susi; Rebecca Rossetti; Maria Elena Spoltore; Davide Masi; Rossella Tozzi; Stefania Mariani; Lucio Gnessi; Carla Lubrano Journal: Cells Date: 2022-08-04 Impact factor: 7.666
Authors: Małgorzata Elżbieta Zujko; Anna Waśkiewicz; Anna Maria Witkowska; Danuta Szcześniewska; Tomasz Zdrojewski; Krystyna Kozakiewicz; Wojciech Drygas Journal: Oxid Med Cell Longev Date: 2018-03-26 Impact factor: 6.543